# Jeena Sikho Lifecare share price today (Jeena Sikho Lifecare Ltd, NSE: JSLL) > Jeena Sikho Lifecare share price today: ₹296.35 at the NSE close on 18 November 2026, down 57.2% in a year. Jeena Sikho Lifecare (NSE: JSLL) is worth ₹3,685 crore, trades at a P/E of 15.6 and has closed between ₹296.35 and ₹748.25 over the past 52 weeks. > Jeena Sikho Lifecare Ltd's earnings have grown faster than its share price. Earnings per share grew +177.9% in a year while the price moved −57.2%. JSLL · Ayurvedic · data as of 18 November 2026. Page: https://www.sectoralpha.in/stocks/jeena-sikho-lifecare-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Price: ₹296.35 (−57.2% in a year) - P/E: 15.6× (lower than 100% of the last 4.6 years) - Revenue (Jun 2026): ₹224 Cr (+28.7% on a year ago) - Profit (Jun 2026): ₹66.0 Cr (+29.4% on a year ago) - Operating margin: 41.1% (−4.3 points on a year ago) - ROCE: 64%, FY26 - ROIC: 60.8%, against a 12.0% cost of capital: +48.8 points - Profit that came in as cash: 103%, last 3 years The main question: yearly earnings per share moved +177.9% while the share price moved −57.2%. ## What is the Jeena Sikho Lifecare share price today? Jeena Sikho Lifecare Ltd's share price was ₹296.35 at the close on 18 November 2026. It has been falling for 19 weeks. That is 44.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹296 and ₹748, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 30 weeks running. Over the last 4.6 years the share price moved +1,402% while the NIFTY 500 moved +59%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 5 June 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Jeena Sikho Lifecare this quarter? Three changes stood out: number of shareholders up 193% in a year, foreign funds (FIIs) cut their stake for 4 quarters in a row and revenue up on a year earlier for 5 quarters in a row (every quarter we can compare). 1. Number of shareholders up 193% in a year 47,872 shareholders in the September 2026 quarter, against 16,362 a year earlier. 2. Foreign funds (FIIs) cut their stake for 4 quarters in a row From 6.6% to 4.5% of the company by the September 2026 quarter. 3. Revenue up on a year earlier for 5 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹224 crore, +28.7% on a year earlier. ## What are Jeena Sikho Lifecare's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Jeena Sikho Lifecare reported revenue of ₹224 crore, up 28.7% from ₹174 crore a year earlier, and a profit of ₹66.0 crore, up 29.4% from ₹51.0 crore. ### Jeena Sikho Lifecare results: April to June 2026 against a year earlier | Measure | April to June 2026 | April to June 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹224 crore | ₹174 crore | +28.7% | | Profit | ₹66.0 crore | ₹51.0 crore | +29.4% | | Earnings per share | ₹5.28 | ₹4.13 | +27.8% | | Operating margin | 41.1% | 45.4% | −4.3 points | The next results, for July to September 2026, were due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). This page shows them once our weekly data update has read them. The newest call in our records is from 16 November 2026, about July to September 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.) ## What is the Jeena Sikho Lifecare share price history? Jeena Sikho Lifecare closed at ₹296.35 on 18 November 2026, down 57.2% from ₹691.90 a year earlier (21 November 2025) and up 102.7% over three years. Its highest weekly close since April 2022 was ₹816.20 on 19 September 2025. ### Jeena Sikho Lifecare share price: then and now | When | Close | Change to 18 Nov 2026 | | --- | --- | --- | | 1 week ago · 11 Nov 2026 | ₹362.50 | −18.2% | | 1 month ago · 19 Oct 2026 | ₹369.75 | −19.9% | | 6 months ago · 15 May 2026 | ₹639.10 | −53.6% | | 1 year ago · 21 Nov 2025 | ₹691.90 | −57.2% | | 3 years ago · 17 Nov 2023 | ₹146.20 | +102.7% | | Earliest weekly close in our records · 22 Apr 2022 | ₹19.73 | +1,402.0% | | Highest weekly close since April 2022 · 19 Sep 2025 | ₹816.20 | −63.7% | | Lowest weekly close since April 2022 · 24 Jun 2022 | ₹15.33 | +1,833.1% | | 52-week high (weekly close) · 8 May 2026 | ₹748.25 | −60.4% | | 52-week low (weekly close) · 18 Nov 2026 | ₹296.35 | 0.0% | Weekly closing prices. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (245 weekly closes from 22 April 2022 to 18 November 2026.) ## What is the latest news on Jeena Sikho Lifecare? 18 Nov 2026: Jeena Sikho Lifecare closed at ₹296.35, down 18.2% on the week and down 19.9% on the month. 16 Nov 2026: Jeena Sikho Lifecare held its results call for July to September 2026. Management guided: FY27 sales growth 20-25% reiterated, next-year growth 25-30% planned overall. ### Earlier - 21 Sep 2026: ex-date for a dividend of ₹4.50 a share. - Results for April to June 2026: Revenue up 28.7% and profit up 29.4% on a year earlier. ## What dividend does Jeena Sikho Lifecare pay? Jeena Sikho Lifecare paid ₹4.50 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 1.52% at the ₹296.35 close on 18 November 2026. The last was a dividend of ₹4.50 a share, ex-date 21 September 2026. ### Jeena Sikho Lifecare dividends since 1 April 2021 | Ex-date | Dividend per share | Type | | --- | --- | --- | | 21 Sep 2026 | ₹4.50 | Dividend | | 22 Sep 2025 | ₹1.10 | Dividend | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 1 of 5 Of the last 5 financial years, years with an NSE dividend record Yes. Jeena Sikho Lifecare Ltd paid out 25% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 8 reported years. (From the NSE corporate-actions record, read 18 November 2026.) ## What did Jeena Sikho Lifecare management say on the latest results call? On the call for July to September 2026, held on 16 November 2026, Jeena Sikho Lifecare's management guided: FY27 sales growth 20-25% reiterated, next-year growth 25-30% planned overall. > “People are placing their trust in us, and in this quarter we increased that trust, but at the cost of margins. Our task now is to convert that trust back into profit.” > Manish Grover, on the call for July to September 2026 ### What management guided - Q4 plus next-year operating profit 35-40% planned with only limited Q3 lift expected. - Monthly sales ₹90-95 crore over December-March toward ₹1,000 crore year. - Beds about 2,900 operational before March 31 on Lucknow and Ahmedabad starts; 7,000-10,000 beds in 3-5 years with turnover ₹2,000-3,000 crore. - Ticket restoration to ₹8,200-8,400 band over next 2-3 quarters on core protocol return. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/45731-16-Nov-2026.pdf). (From the call for July to September 2026, 16 November 2026.) ## What to watch in Jeena Sikho Lifecare's next results? When Jeena Sikho Lifecare reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Occupancy recovery from Diwali-week low on restored core protocols and day-care conversion - verify volume and stay mix. Management raised each of these on the latest results call. - Occupancy recovery from Diwali-week low on restored core protocols and day-care conversion - verify volume and stay mix. - Ticket repair toward flagged band as preventive packages rebalanced with treatment Panchakarma - verify realization path. - Conversion of expanded e-commerce household base into hospital Panchakarma without renewed acquisition spike - verify funnel yield. - Portal 2.0 collections within flagged window while keeping government share within cap - verify receivables and payer mix. ## Which stock lists is Jeena Sikho Lifecare on? Jeena Sikho Lifecare is not on any of our India lists this week. ## Is Jeena Sikho Lifecare profitable? Jeena Sikho Lifecare Ltd earned ₹66.0 Cr of net profit in the Jun 2026 quarter, +29.4% on the same quarter a year earlier. That is the 5th quarter in a row of profit growth. Full-year FY26 profit was ₹222 Cr. Over 7 years profit has grown 67.5% a year on average. The same quarter a year earlier earned ₹51.0 Cr. The Jun 2026 quarter's profit is 29.5% of that quarter's revenue. For the full year, FY26 profit was ₹222 Cr (+177.5% on the year before). Why profit moved: revenue changed +28.7% on a year earlier and the margin moved −4.3 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +160.8% and revenue +60.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Jeena Sikho Lifecare make, and is it growing? Jeena Sikho Lifecare Ltd reported ₹224 Cr of revenue in the Jun 2026 quarter, +28.7% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 7 years it has grown 33.5% a year on average. The last full year, FY26, came in at ₹801 Cr. The last four reported quarters add to ₹852 Cr. FY26 revenue was ₹801 Cr, +70.8% on the year before. Recent pace: the last four quarters grew +60.6% on average, against 33.5% a year over the longer run, so this year is growing faster than its own long-run rate. ## How much of every ₹100 of sales does Jeena Sikho Lifecare keep? Jeena Sikho Lifecare Ltd's operating margin was 41.1% in the Jun 2026 quarter, 4.3 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 8 years it has been between 10.4% and 43.8%. The latest quarter is within that range. Why the margin moved: operating margin changed −4.2 percentage points on the year while gross margin changed −5.1 points. So the drop came mostly from the gross margin, which means input costs and prices charged. As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead. ## Is Jeena Sikho Lifecare's profit turning into cash? Over the last 3 years, 103% of Jeena Sikho Lifecare Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹262 Cr of operating cash against ₹222 Cr of profit. After ₹34.0 Cr of spending on assets, ₹220 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 103% of profit came in as cash: the cash cycle got 117 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Jeena Sikho Lifecare's cash go? Jeena Sikho Lifecare Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 26 days in FY26, down from 143 days in FY21. It spent ₹92.0 Cr on assets over the last 3 years. Customers take 32 days to pay, and stock sits for 80 days on average. At FY26 sales of ₹801 Cr, each day of that cycle ties up about ₹2.2 Cr, so roughly ₹57.0 Cr is tied up in the business at any time. FY26: customers took 32 days to pay and stock sat for 80 days, about 2.6 months of sales sitting as stock, for a full cycle of 26 days, shorter than FY21's 143. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 80 days. Customers pay about 32 days after that. Suppliers are paid at 86 days. Together that makes the 26-day cycle. Spending on assets: ₹92.0 Cr over the last 3 years, against ₹82.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹3.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Jeena Sikho Lifecare's P/E ratio, and how does it compare with its own history? Jeena Sikho Lifecare Ltd's P/E is 15.6×, about the lowest it has ever been. Its usual P/E (the middle reading) is 41.5×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks. Why the multiple is where it is: over the past year earnings per share moved +177.9% while the price moved −57.2%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved +26.6% a year; about +92.1% a year came from earnings growth and about −65.5 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Jeena Sikho Lifecare business getting better or worse? Jeena Sikho Lifecare Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 8 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Jeena Sikho Lifecare earn on its capital? Jeena Sikho Lifecare Ltd earned a ROCE of 64% in FY26. That is up from a low of 38% in FY20. Its return on capital used (ROIC) is 48.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 27.7% net margin and 1.19× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 27.7% net margin × 1.19× asset turnover × 1.44× leverage (assets divided by equity) ≈ 47.5% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 60.8% − 12.0% = +48.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. The 60.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 62.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Jeena Sikho Lifecare have too much debt? Jeena Sikho Lifecare Ltd has total debt of ₹127 Cr against shareholder equity of ₹468 Cr as of Mar 2026, so its debt is 0.27× its equity, which is very little. Year by year, that ratio went from 0.01 in FY23 to 0.27 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Jeena Sikho Lifecare shareholding pattern? Promoters cut their stake in Jeena Sikho Lifecare Ltd by 4.2 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 63.7% of the company. Foreign institutions moved +4.2 points over the same period, to 4.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −4.2 points over 8 quarters, to 63.7%; Foreign institutions: +4.2 points over 8 quarters, to 4.5%; Domestic institutions: +0.5 points over 8 quarters, to 0.5%. Why the owners changed: promoters drove it (−4.2 points), with the other side taken by foreign institutions (+4.2 points). They reduced their stake. ## How far is Jeena Sikho Lifecare from balance-sheet trouble? For Jeena Sikho Lifecare Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Jeena Sikho Lifecare rank in its industry? 76.0 out of 100, rank 1 of 1 in Ayurvedic, with 82% of the evidence available. Jeena Sikho Lifecare Ltd scores 76.0 out of 100 against the 1 companies it is compared with in Ayurvedic, ranking 1. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 28 + 22 + 18.5 + 7.5 = 76. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Jeena Sikho Lifecare compared with? Jeena Sikho Lifecare ranks 1 of 1 Ayurvedic companies on the 4-Factor Sector Score, with 76.0 out of 100. 1. Jeena Sikho Lifecare Ltd this page JSLL · quiet · Most evidence points up · 82% evidence 76.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.0/35 · Revenue 56.9% · Profit 100% · Operating margin change -4 points · 100% evidence Capital efficiency 22.0/25 · ROCE 64.4% (year to Mar 2026) · Operating margin 41.1% · 100% evidence Valuation 18.5/20 · P/E 15.6× · PEG 0.39 · 85% evidence Relative strength 7.5/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -44% · 1 year -57.2% · 25% evidence · 0 of 12 weeks ahead Exact sum: 28 + 22 + 18.5 + 7.5 = 76 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Ayurvedic](https://www.sectoralpha.in/sectors/ayurvedic), all 1 compared on one page. ## Which companies are close to Jeena Sikho Lifecare in size? Jeena Sikho Lifecare is the only Ayurvedic company on Sector Alpha, so the companies closest to it in market value across all industries are listed: Symphony, Kalyani Steels, MPS and Rallis India. ### Companies close in size in other industries 1. [Symphony Ltd](https://www.sectoralpha.in/stocks/symphony-ltd) ₹3,687 crore · Consumer Electronics 2. [Kalyani Steels Ltd](https://www.sectoralpha.in/stocks/kalyani-steels-ltd) ₹3,686 crore · Steel Products 3. Jeena Sikho Lifecare Ltd ₹3,684 crore 4. [MPS Ltd](https://www.sectoralpha.in/stocks/mps-ltd) ₹3,683 crore · E-Commerce - Platform - Utility 5. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) ₹3,682 crore · Pesticides/Agrochemicals ## What else do people ask about Jeena Sikho Lifecare? ### What is Jeena Sikho Lifecare's share price today? Jeena Sikho Lifecare Ltd's share price is ₹296.35, −57.2% over the past year. The whole company is worth ₹3,685 Cr on the market. It is at its lowest price of the past 52 weeks (range ₹296 to ₹748), 44.0% below its 200-day average. The price has been falling for 19 weeks (as of 18 November 2026). ### What were Jeena Sikho Lifecare's latest quarterly results? Jeena Sikho Lifecare Ltd reported revenue of ₹224 Cr and net profit of ₹66.0 Cr for the Jun 2026 quarter. Revenue rose 28.7% and profit rose 29.4% compared with a year earlier. Earnings per share were ₹5.28. The operating margin was 41.1%, 4.3 percentage points lower than a year earlier (as of 18 November 2026). ### What is Jeena Sikho Lifecare's market cap? Jeena Sikho Lifecare Ltd's market capitalisation is ₹3,685 Cr at a share price of ₹296.35. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026). ### How is Jeena Sikho Lifecare performing? Jeena Sikho Lifecare Ltd's share price has been falling for 19 weeks. In its latest quarter, revenue rose 28.7% and profit rose 29.4% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 30 weeks running (as of 18 November 2026). ### Will Jeena Sikho Lifecare's share price go up? This page does not forecast Jeena Sikho Lifecare Ltd's share price. What it shows instead: the share price is ₹296.35, and it has been falling for 19 weeks. Its P/E of 15.6× is higher than 0% of its own last 5 years (as of 18 November 2026). ### Who owns Jeena Sikho Lifecare? Promoters own 63.7% of Jeena Sikho Lifecare Ltd, foreign institutions 4.5%, domestic institutions 0.5% and the public 31.3% (latest quarter). The biggest change over the last two years: Promoters cut their stake by 4.2 percentage points over 8 quarters (as of 18 November 2026). ### Where is Jeena Sikho Lifecare in its business cycle? Jeena Sikho Lifecare Ltd's FY26 operating margin was 43.8%, against a 8-year range of 10.4% to 43.8%. The latest quarter was 41.1%, the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026). ### What could break the Jeena Sikho Lifecare story? The main question: yearly earnings per share moved +177.9% while the share price moved −57.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026). ### Is Jeena Sikho Lifecare a stock worth studying right now? What the numbers show: Jeena Sikho Lifecare Ltd's earnings have grown faster than its share price. Earnings per share grew +177.9% in a year while the price moved −57.2%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026). ### Is there a Jeena Sikho Lifecare share price forecast for 2026? What management itself guided: FY27 sales growth 20-25% reiterated, next-year growth 25-30% planned overall. This is research, not advice. We’re not SEBI-registered.